(Q33366632)

26 July 2017

1 reference

title

Minimising the risk of heparin-induced osteoporosis during pregnancy (English)

1 reference

26 July 2017

0 references

David Hawkins

1

1 reference

26 July 2017

Jeffrey Evans

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Expert Opinion on Drug Safety

26 July 2017

published in

1 reference

26 July 2017

volume

4

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

583-590

1 reference

Clinical use of bone densitometry: scientific review

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Invited Review: Pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

21 January 2018

Drug-induced bone loss

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Dosing and monitoring of low-molecular-weight heparins in special populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Low molecular weight heparins: a guide to their optimum use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

A low-molecular-weight heparin preparation contraindicated during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

Enoxaparin treatment in women with mechanical heart valves during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.583

21 January 2018

Identifiers

DOI

10.1517/14740338.4.3.583

1 reference

26 July 2017

1 reference